Manley PW - Search Results

1

Erratum to: Imatinib relaxes the pulmonary venous bed of guinea pigs.

Maihöfer NA, Suleiman S, Dreymüller D, Manley PW, Rossaint R, Uhlig S, Martin C, Rieg AD. Maihöfer NA, et al. Among authors: manley pw. Respir Res. 2017 Jun 19;18(1):121. doi: 10.1186/s12931-017-0612-z. Respir Res. 2017. PMID: 28629421 Free PMC article. No abstract available.

2

Imatinib relaxes the pulmonary venous bed of guinea pigs.

Maihöfer NA, Suleiman S, Dreymüller D, Manley PW, Rossaint R, Uhlig S, Martin C, Rieg AD. Maihöfer NA, et al. Among authors: manley pw. Respir Res. 2017 Feb 8;18(1):32. doi: 10.1186/s12931-017-0514-0. Respir Res. 2017. PMID: 28178968 Free PMC article.

3

Tyrosine kinase inhibitors relax pulmonary arteries in human and murine precision-cut lung slices.

Rieg AD, Bünting NA, Cranen C, Suleiman S, Spillner JW, Schnöring H, Schröder T, von Stillfried S, Braunschweig T, Manley PW, Schälte G, Rossaint R, Uhlig S, Martin C. Rieg AD, et al. Among authors: manley pw. Respir Res. 2019 Jun 6;20(1):111. doi: 10.1186/s12931-019-1074-2. Respir Res. 2019. PMID: 31170998 Free PMC article.

4

The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase.

Manley PW, Barys L, Cowan-Jacob SW. Manley PW, et al. Leuk Res. 2020 Nov;98:106458. doi: 10.1016/j.leukres.2020.106458. Epub 2020 Sep 29. Leuk Res. 2020. PMID: 33096322 Review.

5

Imatinib: a selective tyrosine kinase inhibitor.

Manley PW, Cowan-Jacob SW, Buchdunger E, Fabbro D, Fendrich G, Furet P, Meyer T, Zimmermann J. Manley PW, et al. Eur J Cancer. 2002 Sep;38 Suppl 5:S19-27. doi: 10.1016/s0959-8049(02)80599-8. Eur J Cancer. 2002. PMID: 12528769 Review.

6

Investigations into the Potential Role of Metabolites on the Anti-Leukemic Activity of Imatinib, Nilotinib and Midostaurin.

Manley PW. Manley PW. Chimia (Aarau). 2019 Aug 21;73(7-8):561-570. doi: 10.2533/chimia.2019.561. Chimia (Aarau). 2019. PMID: 31431216 Free article.

7

Tyrosine kinase inhibitors: from rational design to clinical trials.

Traxler P, Bold G, Buchdunger E, Caravatti G, Furet P, Manley P, O'Reilly T, Wood J, Zimmermann J. Traxler P, et al. Med Res Rev. 2001 Nov;21(6):499-512. doi: 10.1002/med.1022. Med Res Rev. 2001. PMID: 11607931 Review.

8

Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib.

Manley PW, Stiefl N, Cowan-Jacob SW, Kaufman S, Mestan J, Wartmann M, Wiesmann M, Woodman R, Gallagher N. Manley PW, et al. Bioorg Med Chem. 2010 Oct 1;18(19):6977-86. doi: 10.1016/j.bmc.2010.08.026. Epub 2010 Aug 14. Bioorg Med Chem. 2010. PMID: 20817538

9

The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588.

Manley PW, Blasco F, Mestan J, Aichholz R. Manley PW, et al. Bioorg Med Chem. 2013 Jun 1;21(11):3231-9. doi: 10.1016/j.bmc.2013.03.038. Epub 2013 Apr 1. Bioorg Med Chem. 2013. PMID: 23611771

10

Imatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment.

Cowan-Jacob SW, Guez V, Fendrich G, Griffin JD, Fabbro D, Furet P, Liebetanz J, Mestan J, Manley PW. Cowan-Jacob SW, et al. Among authors: manley pw. Mini Rev Med Chem. 2004 Mar;4(3):285-99. doi: 10.2174/1389557043487321. Mini Rev Med Chem. 2004. PMID: 15032675 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters